Biology subjects

Janning, P.

Publications and source records attributed to Janning, P..

14 recordsLinked to original sources

bioRxiv2026

Assembly principles of a SYCP2-HORMAD1-HORMAD2 mammalian meiotic axis complex

During meiotic prophase I, the chromosome axis orchestrates programmed DNA double-strand break formation, repair and synapsis between homologous chromosomes. In mammals, the axis is assembled from the coiled-coil elements SYCP2 and SYCP3 that come together with the HORMA-domain proteins HORMAD1 and HORMAD2, but how these components associate into a coherent structural unit remains incompletely understood. Combining recombinant reconstitution, mass photometry, SEC-MALS, AlphaFold modelling and crosslinking mass spectrometry, we show that the HORMA domains of HORMAD1 and HORMAD2 form a selective pseudosymmetric heterodimer independently of either proteins own closure motif, with interface determinants conserved across vertebrates. We identify a previously unrecognised second closure motif (CM2) in SYCP2 that preferentially binds HORMAD1, distinct from the previously described HORMAD2-binding closure motif (CM1). Together, these results revise the current model of mammalian axis assembly and define a tripartite SYCP2-HORMAD1-HORMAD2 module as a fundamental structural unit of the mammalian meiotic chromosome axis.

cell biology↗

bioRxiv2026

The Legionella phosphocholinase AnkX modulates IMPDH2 regulation and cytoophidia dynamics

Legionella pneumophila, the causative agent of Legionnaires disease, secretes more than 300 different effector proteins into the host cell to modulate processes such as signal transduction, membrane dynamics, and metabolism. A key regulator of cellular metabolism and proliferation is inosine 5-monophosphate dehydrogenase type II (IMPDH2), which catalyzes the rate-limiting step of de novo GTP biosynthesis. IMPDH2 assembles into filaments and larger structures known as cytoophidia, which enable fine-tuned regulation of enzymatic activity in response to changing nucleotide demands. Here, we identify human IMPDH2 as a previously unrecognized host target of the Legionella effector AnkX. We show that AnkX post-translationally modifies IMPDH2 within its regulatory domain by covalently attaching a phosphocholine moiety. While this post-translational modification does not alter the catalytic activity of IMPDH2, it disrupts filament formation, thereby impairing nucleotide-dependent regulation of enzyme activity. Consequently, AnkX-mediated phosphocholination affects IMPDH2 filament assembly, cytoophidia formation, and subcellular localization to the specific Legionella-containing vacuole (LCV). Thus, L. pneumophila subverts host GTP metabolism by posttranslationally modifying a central enzyme of the GTP biosynthetic pathway. Graphical abstract description O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=170 SRC="FIGDIR/small/701698v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@18f7724org.highwire.dtl.DTLVardef@1d70e86org.highwire.dtl.DTLVardef@1fa8890org.highwire.dtl.DTLVardef@11bc5ba_HPS_FORMAT_FIGEXP M_FIG C_FIG The Legionella effector AnkX post-translationally modifies the human host enzyme IMPDH2 by transferring a phosphocholine group using CDP-choline as co-substrate. We identified the modification site and discovered that this post-translational modification disrupts the ability of IMPDH2 to assemble into filaments and cytoophidia. By shifting the equilibrium toward free octamers, AnkX-mediated PCylation perturbs the structural regulation of IMPDH2 and alters GTP metabolism in L. pneumophila-infected host cells. This figure was inspired by (https://www.biorxiv.org/content/10.1101/2024.07.29.605679v2).

microbiology↗

bioRxiv2025

Mammalian Proteome Profiling Reveals Readers and Antireaders of Strand-Symmetric and -Asymmetric 5-Hydroxymethylcytosine-Modifications in DNA

The cytosine (C) modifications 5-methylcytosine (mC) and 5-hydroxymethylcytosine (hmC) are central regulatory elements of mammalian genomes. Both marks occur in dinucleotide contexts of double stranded DNA in either strand-symmetric or -asymmetric fashion, but it is still poorly understood how this symmetry information is selectively read out by the nuclear proteome as basis of potential symmetry-dependent regulation mechanisms. We report comparative enrichment/proteomics studies with promoter probes being strand-symmetrically or asymmetrically modified with C, mC and hmC, enabling a direct assessment of their reader profiles in the same sequence, tissue, and experimental contexts. We identify in human and mouse nuclear lysates a high number of tissue-specific readers for hmC-modified sequences that fall into distinct, probe-specific sub-groups, including members of important transcription factor classes and chromatin regulators. Among them, we discover the master regulators MYC and MAX that play central roles in cell (de)differentiation and cancer progression to read hmC in a sequence-dependent manner. We also find RFX5, a transcription factor critically involved in primary MHC class II deficiency to discriminate between specific hmC symmetries in CpG dyads. Our findings provide further support for the hypothesis that hmC symmetry information can provide distinct regulatory outputs, and provide a resource for studying the molecular mechanisms triggered by symmetric and asymmetric hmC modifications in chromatin regulation during development and disease.

biochemistry↗

bioRxiv2025

Molecular anatomy of PLK1 master docking motifs

The Polo-box domain (PBD) localizes Polo-like kinase 1 (PLK1) near mitotic substrates required for chromosome biorientation. Recent work on mitotic kinetochores showed PLK1 docking begins hierarchically at master docking motifs on BUB1 and CENP-U. Whether master docking motifs have common molecular features remains poorly understood. Presence on CENP-U of two neighbouring motifs generated by initial CDK1 priming and subsequent PLK1 phosphorylation led us to hypothesize PBD dimerization might be involved. Using biochemical, biophysical, and modelling approaches, we gathered strong evidence that CENP-U contains a single master docking motif. The motif is very high affinity and sufficient to form extensive interactions with the PBD, engaging multiple pockets on its surface without obvious added benefits from dimerization. Comparisons with motifs in BUB1, BUBR1, and PRC1 suggests apparent commonalities of master PLK1 docking motifs. We discuss the implications of our observations for the mechanism of PLK1 activation.

biochemistry↗

bioRxiv2024

Monovalent Pseudo-Natural Product Degraders Supercharge the Native Degradation of IDO1 by KLHDC3

Targeted protein degradation (TPD) modulates protein function beyond inhibition of enzyme activity or protein-protein interactions. Most degrader drugs function by directly mediating proximity between a neosubstrate and hijacked E3 ligase. Here, we identified pseudo-natural products derived from (-)-myrtanol, termed iDegs that inhibit and induce degradation of the immunomodulatory enzyme indoleamine-2,3-dioxygenase 1 (IDO1) by a distinct mechanism. iDegs boost IDO1 ubiquitination and degradation by the cullin-RING E3 ligase CRL2KLHDC3, which we identified to natively mediate ubiquitin-mediated degradation of IDO1. Therefore, iDegs increase IDO1 turnover using the native proteolytic pathway. In contrast to clinically explored IDO1 inhibitors, iDegs reduce formation of kynurenine by both inhibition and induced degradation of the enzyme and, thus, would also modulate non-enzymatic functions of IDO1. This unique mechanism of action may open up new therapeutic opportunities for the treatment of cancer beyond classical inhibition of IDO1.

cell biology↗

bioRxiv2024

Biochemical and structural insights into the auto-inhibited state of Mical1 and its activation by Rab8

Mical1 regulates F-actin dynamics through the reversible oxidation of actin, a process controlled by its interactions with various proteins. Upon binding to Rab8 family members, Mical1 links endosomes to the cytoskeleton, promoting F-actin disassembly. In the absence of Rab, Mical1 exists in an auto-inhibited state, but its biochemical characterization remains incomplete. Our study reveals that the N-terminal MO-CH-LIM domains of Mical1 form an intramolecular complex with its C-terminal bMERB domain. Mutational analysis, guided by the AlphaFold2 model, identifies critical residues at the binding interface. Additionally, we demonstrate that full-length Mical1 binds to Rab8 in a 1:2 stoichiometry, thereby releasing auto-inhibition. Through structure-based mutational studies, we uncover allostery between the N and C-terminal Rab binding sites. Notably, Rab binding at the high-affinity C-terminal site precedes binding at the N-terminal site, suggesting a sequential binding mode. These findings elucidate how Rab8 binding releases the MO-CH-LIM domains from the Mical1 bMERB domain, facilitating interactions with other proteins and the actin cytoskeleton, thereby modulating actin dynamics.

biochemistry↗

bioRxiv2023

Discovery of the sEH Inhibitor Epoxykynin as Potent Kynurenine Pathway Modulator

Disease-related phenotypic assays enable unbiased discovery of novel bioactive small molecules and may provide novel insights into physiological systems and unprecedented molecular modes-of-action (MMOA). Herein we report the identification and characterization of epoxykynin, a potent inhibitor of the soluble epoxide hydrolase (sEH). Epoxykynin was discovered by means of a cellular assay monitoring modulation of kynurenine (Kyn) levels in BxPC-3 cells upon stimulation with the cytokine interferon-{gamma} (IFN-{gamma}) and subsequent target identification employing affinity-based chemical proteomics. Increased Kyn levels are associated with immune suppression in the tumor microenvironment and, thus, the Kyn pathway and its key player indoleamine 2,3-dioxygenase 1 (IDO1) are appealing targets in immuno-oncology. However, targeting IDO1 directly has led to limited success in clinical investigations, demonstrating that alternative approaches to reduce Kyn levels are in high demand. We uncover a cross-talk between sEH and the Kyn pathway that may provide new opportunities to revert cancer-induced immune tolerance.

cell biology↗

bioRxiv2023

Detection of a Mitochondrial Stress Phenotype using the Cell Painting Assay

Mitochondria are cellular powerhouses and crucial for cell function. However, these organelles are vulnerable to internal and external perturbagens that may impair mitochondrial function and eventually lead to cell death. In particular, small molecules may impact mitochondrial function and cardio- or hepatotoxicity caused by numerous drugs links mitochondrial toxicity to these adverse effects. Therefore, the influence of small molecules on mitochondrial homeostasis is at best assessed early on in the characterization of biologically active small molecules and drug discovery. We demonstrate that unbiased morphological profiling by means of the Cell Painting assay (CPA) can detect mitochondrial stress coupled to the induction of integrated stress response. This activity is common for compounds addressing different targets, is not shared by direct inhibitors of the electron transport chain and enables prediction of mitochondrial stress induction for small molecules that are profiled using CPA.

cell biology↗

bioRxiv2023

Specialized pathogenic cells release Tc toxins using a type 10 secretion system

Disease-causing bacteria use a variety of secreted toxins to invade and subjugate their hosts. While the machinery responsible for secretion of many smaller toxins has already been established, it remains enigmatic for larger ones such as Tc toxins from human and insect pathogens, which approach the size of a prokaryotic ribosome. In the present study, we combine targeted genomic editing, proteomic profiling and cryo-electron tomography of the insect pathogen Yersinia entomophaga to reveal that a specialized subset of bacterial cells produces the Tc toxin YenTc as part of a complex toxin cocktail released into the environment by controlled cell lysis using a transcriptionally-coupled, pH-dependent type 10 secretion system (T10SS). Our results dissect the process of Tc toxin export by a T10SS in hitherto unprecedented detail, identifying that T10SSs operate via a previously unknown lytic mode of action, and establishing them as crucial players in the size-insensitive release of cytoplasmically folded toxins. With T10SSs directly embedded in Tc toxin operons of major human pathogens such as Yersinia pestis and Salmonella enterica, we anticipate our findings to model an important aspect of pathogenesis in bacteria with a significant impact on global human health.

microbiology↗

bioRxiv2022

Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors

Mutations within Ras proteins represent major drivers in human cancer. In this study, we report the structure-based design, synthesis, as well as biochemical and cellular evaluation of nucleotide-based covalent inhibitors for KRasG13C, an important oncogenic mutant of Ras that has not been successfully addressed in the past. Mass spectrometry experiments and kinetic studies reveal promising molecular properties of these covalent inhibitors, and X-ray crystallographic analysis has yielded the first reported crystal structures of KRasG13C covalently locked with these GDP analogues. Importantly, KRasG13C covalently modified with these inhibitors can no longer undergo SOS-catalysed nucleotide exchange. As a final proof-of-concept, we show that in contrast to KRasG13C, the covalently locked protein is unable to induce oncogenic signalling in cells, further highlighting the possibility of using nucleotide-based inhibitors with covalent warheads in KRasG13C-driven cancer.

cancer biology↗

bioRxiv2022

Mer3 helicase protects early crossover intermediates from STR complex disassembly during meiosis

During meiosis I it is necessary that homologous chromosomes are linked to one another so that they can be faithfully separated. S. cerevisiae Mer3 (HFM1 in mammals) is a SF2 helicase and member of the ZMM group of proteins, that facilitates the formation of class I crossovers during meiosis. Here we describe the structural organisation of Mer3 and, using AlphaFold modelling and XL-MS, we further characterise the previously described interaction with Mlh1-Mlh2. We find that Mer3 also forms a previously undescribed complex with the recombination regulating factors Top3 and Rmi1 and that this interaction is competitive with Sgs1BLM helicase in a phospho-dependent manner. Using in vitro reconstituted D-loop assays we show that Mer3 inhibits the anti-recombination activity of Sgs1/Top3/Rmi1 (STR) complex. Thus we provide a mechanism whereby Mer3 downregulates the anti-crossover activity of the STR complex, hence promoting the formation of crossovers during meiosis I.

biochemistry↗

bioRxiv2022

Conformational transitions of the mitotic adaptor Spindly underlie its interaction with Dynein and Dynactin

Cytoplasmic Dynein 1, or Dynein, is a microtubule minus-end directed motor. Dynein motility requires Dynactin and a family of activating adaptors that stabilize the Dynein-Dynactin complex and promote regulated interactions with cargo in space and time. How activating adaptors limit Dynein activation to specialized subcellular locales is unclear. Here, we reveal that Spindly, a mitotic Dynein adaptor at the kinetochore corona, exists natively in a closed conformation that occludes binding of Dynein-Dynactin to its CC1 box and Spindly motif. A structure-based analysis identified various mutations promoting an open conformation of Spindly that binds Dynein-Dynactin. A region of Spindly downstream from the Spindly motif and not required for cargo binding faces the CC1 box and stabilizes the intramolecular closed conformation. This region is also required for robust kinetochore localization of Spindly, suggesting that kinetochores promote Spindly activation to recruit Dynein. This mechanism may be paradigmatic for Dynein activation by other adaptors at various cellular locales.

biochemistry↗

bioRxiv2021

Reconstitution and use of highly active human CDK1:Cyclin-B:CKS1 complexes

As dividing cells transition into mitosis, hundreds of proteins are phosphorylated by a complex of cyclin-dependent kinase 1 (CDK1) and Cyclin-B, often at multiple sites. CDK1:Cyclin-B phosphorylation patterns alter conformations, interaction partners, and enzymatic activities and need to be recapitulated in vitro for the structural and functional characterization of the mitotic protein machinery. This requires a pure and active recombinant kinase complex. The kinase activity of CDK1 critically depends on the phosphorylation of a Threonine residue in its activation loop by a CDK1 activating kinase (CAK). We developed protocols to activate CDK1:Cyclin-B either in vitro with purified CDK1 activating kinases (CAK) or in insect cells through CDK-CAK co-expression. To boost kinase processivity, we reconstituted a tripartite complex consisting of CDK1, Cyclin-B, and CKS1. In this work, we provide and compare detailed protocols to obtain and use highly active CDK1:Cyclin-B (CC) and CDK1:Cyclin-B:CKS1 (CCC).

biochemistry↗

bioRxiv2020

14-3-3 protein Bmh1 triggers short-range compaction of mitotic chromosomes by recruiting sirtuin deacetylase Hst2

Mitotic chromosome compaction is licensed by kinetochores in yeast. Recruitment of Aurora kinase B elicits a cascade of events starting with phosphorylation of H3 S10, which signals the recruitment of lysine deacetylase Hst2 and the removal of H4 K16ac. The unmasked H4 tails interact with the acidic patch of neighbouring nucleosomes to drive short-range compaction of chromatin. Here, we demonstrate that the interaction of Hst2 with H3 S10ph is mediated by 14-3-3 protein Bmh1. As a homodimer, Bmh1 binds simultaneously to H3 S10ph and the phosphorylated C-terminus of Hst2. The Hst2-Bmh1 interaction is cell cycle dependent, reaching its maximum in M phase. Furthermore, we show that phosphorylation of C-terminal residues of Hst2 stimulates its deacetylase activity. Hence, the data presented here identify Bmh1 as a key player in the mechanism of licensing of chromosome compaction in mitosis. Key PointsO_LI14-3-3 protein Bmh1 bridges the interaction of Hst2 with phosphorylated H3 tails C_LIO_LIHst2 is multiply phosphorylated on its unstructured C-terminal tail C_LIO_LIThe interaction of Bmh1 with Hst2 is cell cycle dependent C_LIO_LIHst2 phosphorylation enhances its enzymatic activity C_LI

biochemistry↗